Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial

Diabetes - GeneralType 2 Diabetes
Do you want to read an article? Please log in or register.